Optimal dosing of high-dose melphalan prior to autologous hematopoietic stem cell transplantation in a patient with AL amyloidosis and a solitary kidney

Hematol Oncol Stem Cell Ther. 2016 Jun;9(2):86-8. doi: 10.1016/j.hemonc.2015.08.001. Epub 2015 Aug 17.

¹ Amyloidosis Center, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA; Section of Hematology/Oncology, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA.
² Amyloidosis Center, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA; Section of Nephrology, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA.
³ Amyloidosis Center, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA; Section of Hematology/Oncology, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA. Electronic address: [email protected].

No abstract available

Publication types